Designation of Hemophilia Home Treatment Providers Following the September 2005 Annual Application Period

State of New Jersey DEPARTMENT OF BANKING AND INSURANCE LEGISLATIVE AND REGULATORY AFFAIRS PO BOX 325 TRENTON, NJ 08625-0325 JON S. CORZINE STEVEN M. GOLDMAN Governor TEL (609) 984-3602 FAX (609) 292-0896 Acting Commissioner Visit us on the Web at www.njdobi.org New Jersey is an Equal Opportunity Employer • Printed on Recycled Paper and Recyclable BULLETIN 06-08 TO: All Carriers Subject to the Health Care Quality Act, P.L. 1997, c. 192 (generally codified as N.J.S.A. 26:2S-1 et seq.) FROM: Steven M. Goldman, Acting Commissioner RE: Designation of Hemophilia Home Treatment Providers following the September 2005 Annual Application Period In accordance with N.J.S.A. 26:2S-10.1, the Department of Banking and Insurance (Department) is required to develop a list of providers determined to be eligible to provide home treatment services for hemophilia (designated hemophilia home treatment providers) with which carriers are permitted to contract for the provision of hemophilia home treatment on an innetwork basis when a carrier is offering health benefits plans that are managed care plans. Rules promulgated at N.J.A.C. 8:38C-2, implementing the provisions of N.J.S.A. 26:2S-10.1 through 10.3, establish procedures and standards by which providers may submit applications to become designated hemophilia home treatment providers. In accordance with the rules, the Department accepts applications annually in the month of September.1 Following review of applications received in September of 2005, requests for additional information, and review of the additional materials submitted, the Department is adding three companies to the list of designated hemophilia home treatment providers. The list is reprinted here in full, with the newest designees indicated by an asterisk. The companies listed below shall continue to be so designated until September 30, 2008, in accordance with N.J.A.C. 8:38C- 2.9, unless there is a change in the status of the designee that makes the designee ineligible for the designation at an earlier date: 1. ADIMA d/b/a BioScrip, effective as of April 12, 2005; 2. ACCREDO Health Group, Inc., effective as of April 12, 2005; 3. Caremark Rx, Inc., effective as of April 12, 2005; 4. Children’s Hospital Home Care, effective as of April 12, 2005 for the following counties: Atlantic, Burlington, Camden, Cape May, Cumberland, Gloucester, Hunterdon, Mercer, Middlesex, Monmouth, Ocean, Salem and Somerset; 5. *Corum Alternative Site Serivces, Inc., effective as of February 27, 2006; 1 The Department also accepted applications during an initial period following the effective date of the rules, and thus, applications were initially accepted through February 8, 2005. 2 6. *Curative Critical Care Systems, effective as of February 27, 2006; 7. Hemophilia Resources of America, effective as April 12, 2005; 8. *New Life Homecare, Inc., effective as of February 27, 2006 for the following counties: Essex, Union, Morris, Passaic, Bergen, Monmouth, Ocean, Hudson and Middlesex; and 9. Pediatric Services of America, Inc., effective as of April 12, 2005. It may be noted that in a prior public notice issued by the Department of Health and Senior Services,2 it had been stated incorrectly that designation for a company might cease as of August 31, 2008 in the event that the company failed to submit a renewal application. In accordance with N.J.A.C. 8:38C-2.9, a company whose designation is scheduled to end as of September 30, 2008 should file an application to renew its designation no later than August 31, 2008 in order to avoid a lapse in designation, but the designation will continue in effect through September 30, 2008 regardless of whether a renewal application has been filed, assuming the company continues to otherwise be eligible for the designation. The Department has also reprinted the list of hospitals with outpatient regional hemophilia care enters. The Department recognizes and relies upon the U.S. Department of Health and Human Services’ regional hemophilia treatment center designations for the State of New Jersey for purposes of compliance with N.J.S.A. 26:2S-10.2. The State-recognized outpatient regional hemophilia treatment centers may be found routinely online at http://www.cdc.gov/ncbddd/hbd/htc_list.htm, or by contacting the Maternal and Child Health Bureau within the Health Resources and Services Administration of the U.S. Department of Health and Human Services. The list is as follows: Children’s Hospital of Philadelphia Specialty Center New Jersey Section of Hematology/Oncology 1012 Laurel Oak Road, Building 1014 Voorhees, NJ 08043 HTC ID: 152 Region III Children’s Hospital of New Jersey Newark Beth Israel Medical Center Valerie Fund Children’s Center 201 Lyons Avenue at Osborne Terrace Newark, NJ 07112 HTC ID: 070 Region II Newark Beth Israel Medical Center Adult Hematology Programs 201 Lyons Avenue 2 As originally enacted, the responsibilities and oversight associated with N.J.S.A. 26:2S-10.1 through 10.3 (P.L. 2000, c. 121) were under the jurisdiction of the Department of Health and Senior Services. Pursuant to Reorganization Plan 005-2005, jurisdiction was transferred to the Department of Banking and Insurance as of August 29, 2005. Reorganization Plan 005-2005 was published in the August 1, 2005 New Jersey Register at 2737(a). 3 Newark, NJ 07112 HTC ID: 070 Region II St. Michael’s Medical Center Nadeene Brunini Comprehensive Hemophilia Care Center 268 Martin Luther King, Jr. Blvd. Newark, NJ 07102 HTC ID: 055 Region II UMDNJ – Robert Wood Johnson University Hospital New Jersey Regional Hemophilia Program Division of Hematology One Robert Wood Johnson Place P.O. Box 2601 New Brunswick, NJ 08903-0019 HTC ID: 054 Region II Any discrepancies in the Department’s list of State-recognized outpatient regional hemophilia care centers, and Federally-designated hemophilia treatment centers shall be in favor of the Federally-designated hemophilia treatment center information. A public notice setting forth this information will be published in the New Jersey Register shortly. A copy of this Bulletin and, upon publication in the New Jersey Register, a copy of the public notice, will be posted on the Department’s website at http://www.state.nj.us/dobi/legsregs.htm. 3/2/06 /s/ Steven M. Goldman Date Steven M. Goldman Acting Commissioner INOORD/CMCDbhemo0905